Unknown Origin & Other Cancer Types

FDA Approves Thermo Fisher’s NGS-based CDx Test for RET-Positive Thyroid Cancer

The Oncomine Dx Target test was approved as a CDx for a therapy targeting RET-positive thyroid cancer and RET-positive NSCLC.

Unknown Origin & Other Cancer Types

Screening & Removal of Precancerous Lesions Prevents Anal Cancer

A new study found that routine screening for, and removal of, precancerous anal lesions can significantly reduce the risk of anal cancer.

Unknown Origin & Other Cancer Types

Perception-Based Nanosensor Platform Could Advance Ovarian Cancer Detection

A team of researchers is working toward a new detection method for ovarian cancer, which uses machine learning techniques.

Cerebrospinal Fluid May be able to Identify Aggressive Brain Tumors in Children

Mar 3, 2022 | Unknown Origin & Other Cancer Types

It may be possible to identify the presence of an aggressive brain tumor in children by studying their cerebrospinal fluid, according to new research.

Circulating Tumor DNA Test Predicts Recurrence of Oropharyngeal Cancer Post-Treatment

Feb 25, 2022 | Unknown Origin & Other Cancer Types

Blood tests for the detection of circulating tumor DNA can accurately predict recurrence of HPV-driven oropharyngeal cancer following treatment.

Liquid Biopsies Streamline Testing for Cancer Related to HPV

Dec 3, 2021 | Clinical Chemistry Analyzers, Unknown Origin & Other Cancer Types

Researchers developed a blood test for head and neck cancer associated with HPV that was shown to be more accurate and faster than conventional testing.

Genetic Markers for Liver Cancer Found in Blood and Saliva

Nov 26, 2021 | Molecular Diagnostics, Unknown Origin & Other Cancer Types

Researchers examined markers of liver cancer and found that the disease can be recognized by RNA fragments in saliva and blood.

First Results of AI-Based Pathology Diagnostic Tool for Gastric Cancer Announced

Nov 26, 2021 | Digital Imaging, Unknown Origin & Other Cancer Types

The results of research to create an AI-based pathology diagnostic tool with the potential to streamline pathologists’ workloads were recently announced.

Gene Mapping: Multiplex Network Improves Diagnosis, Analysis of Rare Diseases

Nov 15, 2021 | Emerging & Zoonotic Diseases, Sequencing Systems, Unknown Origin & Other Cancer Types

Researchers have developed a mulitiplex network that reveals underlying mechanisms of rare diseases for more accurate identification of genetic defects.

Genetic Testing Could Reduce Rare Pediatric Cancer Deaths by Half

Oct 28, 2021 | Sequencing Systems, Unknown Origin & Other Cancer Types

Genetic testing of the siblings of newborns with cancer genes could reduce rare pediatric cancer deaths by about 50%, an NIH-funded analysis suggests.

Cell-Free DNA IDs Early Signs of Pediatric Medulloblastoma Relapse

Oct 25, 2021 | Amplification Technologies, Unknown Origin & Other Cancer Types

Research shows that cell-free DNA in cerebrospinal fluid can be used to identify patients at risk of pediatric medulloblastoma relapse.

Nonagen’s Bladder Cancer Test Granted FDA Breakthrough Device Designation

Oct 7, 2021 | Immunoassay Reagents & test Kits, Unknown Origin & Other Cancer Types

Nonagen’s non-invasive bladder cancer test has been granted U.S. Food and Drug Administration (FDA) Breakthrough Device Designation.

Sugar Structures Could Identify Early-Stage Liver Cancer

Sep 23, 2021 | Mass Spectrometry, Unknown Origin & Other Cancer Types

Medical University of South Carolina researchers say they have identified specific sugar structures that correlate to liver cancer.

Liquid Biopsy Testing Could be Key to HPV-Derived Cancer Detection

Sep 23, 2021 | Unknown Origin & Other Cancer Types

Investigators say high-risk human papillomaviruses DNA can be detected in the saliva of most patients with HR-HPV that leads to certain types of cancers.

Urine DNA Test Detects Bladder Cancer Data Shows

Sep 14, 2021 | Unknown Origin & Other Cancer Types, Urine Analyzers

Promis Diagnostics recently presented data for CystoChek, a proprietary urine-based DNA methylation test of PENK for bladder cancer detection in hematuria.